Unitedhealth Group INC Form 4 insider transactions

UnitedHealth Group director Michele J. Hooper received 162 deferred stock units as quarterly compensation, increasing her beneficial ownership to 40,877 shares.

UnitedHealth Group Director John H. Noseworthy acquired 261 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 6,693 units.

UnitedHealth Group executive Timothy J. Noel acquired 42.34 shares of common stock via dividend equivalents on restricted stock units.

UnitedHealth Group's Chief Financial Officer, Wayne S. DeVeydt, acquired 66.899 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group Director Kristen Gil acquired 7 shares of common stock through dividend equivalents on vested deferred stock units.

Patrick H. Conway, CEO of Optum, received 64.683 shares of UnitedHealth Group common stock as dividend equivalents on restricted stock units.

UnitedHealth Group CEO Stephen J. Hemsley reported the acquisition of 50 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Paul R. Garcia reported the acquisition of 11 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Timothy Flynn acquired 61 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Michele J. Hooper acquired 236 shares of common stock through dividend equivalents, increasing her beneficial ownership to 40,715 shares.

UnitedHealth Group Director Frederick William McNabb III acquired 49 shares of common stock as dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Charles D. Baker acquired 8 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director John H. Noseworthy acquired 39 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Valerie C. Montgomery Rice M.D. acquired 40 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, acquired 36.837 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's EVP & Chief Legal Officer, Christopher R. Zaetta, is set to acquire 42.53 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, acquired 22.357 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group Director Charles D. Baker reported the sale of 27 shares of common stock at $356.05 per share, executed under a Rule 10b5-1 plan.

UnitedHealth Group's Chief Financial Officer, Wayne S. DeVeydt, was granted 10,525 restricted stock units and 42,551 non-qualified stock options as part of his compensation.

UnitedHealth Group director Paul R. Garcia reported the future acquisition of common stock and deferred stock units as part of his regular quarterly compensation, effective July 1, 2025.

UnitedHealth Group's CEO and Director, Stephen J. Hemsley, reported the acquisition of 198 common stock shares as deferred stock units for director compensation.

UnitedHealth Group Director Timothy Patrick Flynn was granted 288 deferred stock units as part of his regular quarterly compensation, increasing his total beneficial ownership.

UnitedHealth Group director Michele J. Hooper was granted 173 deferred stock units as part of her regular quarterly compensation, increasing her beneficial ownership to 40,479 shares.

UnitedHealth Group director Frederick William McNabb III was granted 294 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 14,003 shares.

UnitedHealth Group Director John H. Noseworthy was granted 288 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 6,393 shares.

UnitedHealth Group director Charles D. Baker was granted 269 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 1,248 shares.

UnitedHealth Group director Valerie Montgomery Rice MD was granted 288 deferred stock units as part of her regular quarterly compensation, increasing her beneficial ownership to 6,587 shares.

UnitedHealth Group Director Kristen Gil reported the acquisition of 173 shares of common stock as part of her regular quarterly compensation for service as a director.

UnitedHealth Group Inc. Director Valerie C. Montgomery Rice M.D. acquired 43 shares of common stock through dividend equivalents on vested deferred stock units.

Patrick H. Conway, CEO of Optum at UnitedHealth Group, acquired 73.058 shares of common stock through dividend equivalents on June 24, 2025, increasing his total beneficial ownership.